VASCULAR COMPLICATIONS AFTER NEO-ADJUVANT PROTOCOL LIVER TRANSPLANTATION FOR SELECTIVE UNRESECTABLE HILAR CHOLANGIOCARCINOMA: MAYO CLINIC FLORIDA EXPERIENCE

被引：0
|
作者：
Panjala, Chakri [1 ]
Harnois, Denise M. [1 ]
Nguyen, Justin H. [1 ]
机构：
[1] Mayo Clin, Jacksonville, FL 32224 USA
来源：
HEPATOLOGY | 2009年 / 50卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1707
引用
收藏
页码：1095A / 1095A
页数：1
相关论文
共 29 条
  • [1] FAVORABLE OUTCOME PREDICTORS OF NEO-ADJUVANT PROTOCOL LIVER TRANSPLANTATION FOR UNRESECTABLE CHOLANGIOCARCINOMA: MAYO CLINIC FLORIDA EXPERIENCE
    Panjala, Chakri
    Nguyen, Justin H.
    Nakhleh, Raouf E.
    Harnois, Denise M.
    [J]. HEPATOLOGY, 2009, 50 (04) : 1094A - 1095A
  • [2] Neoadjuvant Chemoradiotherapy and Liver Transplantation for Unresectable Hilar Cholangiocarcinoma: The Irish Experience of the Mayo Protocol
    Zaborowski, Alexandra
    Heneghan, Helen M.
    Fiore, Barbara
    Stafford, Anthony
    Gallagher, Tom
    Geoghegan, Justin
    Maguire, Donal
    Hoti, Emir
    [J]. TRANSPLANTATION, 2020, 104 (10) : 2097 - 2104
  • [3] SINGLE CENTER VALIDATION OF THE MAYO PROTOCOL FOR LIVER TRANSPLANTATION FOR UNRESECTABLE HILAR CHOLANGIOCARCINOMA
    White, Mattie K.
    Moro, Amika
    Sasaki, Kazunari
    Stephans, Kevin
    Levitin, Abraham
    Estfan, Bassam
    Quintini, Cristiano
    Eghtesad, Bijan
    Hashimoto, Koji
    Miller, Charles
    Aucejo, Federico
    Menon, Kv Narayanan
    [J]. GASTROENTEROLOGY, 2021, 160 (06) : S808 - S809
  • [4] Liver transplantation for hilar cholangiocarcinoma: Update on the Mayo Clinic Protocol and results of living donor liver transplantation.
    Hassoun, Z
    Gores, GJ
    Nagorney, DM
    Nyberg, SL
    Ishitani, MB
    Rosen, CB
    [J]. HEPATOLOGY, 2002, 36 (04) : 228A - 228A
  • [5] Revisiting liver transplantation for patients with hilar cholangiocarcinoma: The Mayo clinic proposal
    Bismuth, H
    [J]. LIVER TRANSPLANTATION, 2000, 6 (03) : 317 - 319
  • [6] Vascular complications after orthotopic liver transplantation after neoadjuvant therapy for hilar cholangiocarcinoma
    Mantel, Hendrik T. J.
    Rosen, Charles B.
    Heimbach, Julie K.
    Nyberg, Scott L.
    Ishitani, Michael B.
    Andrews, James C.
    McKusick, Michael A.
    Haddock, Michael G.
    Alberts, Steven R.
    Gores, Gregory J.
    [J]. LIVER TRANSPLANTATION, 2007, 13 (10) : 1372 - 1381
  • [7] Feasibility of gemcitabine plus cisplatin as neo-adjuvant in cholangiocarcinoma patients prior to liver transplantation
    Esmail, A.
    Xu, J.
    Umoru, G.
    Al-Rawi, H.
    Saharia, A.
    Abdelrahim, M.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 : S310 - S310
  • [8] Gemcitabine and Cisplatin as Neo-Adjuvant for Cholangiocarcinoma Patients Prior to Liver Transplantation: Case-Series
    Abdelrahim, Maen
    Al-Rawi, Hadeel
    Esmail, Abdullah
    Xu, Jiaqiong
    Umoru, Godsfavour
    Ibnshamsah, Fahad
    Abudayyeh, Ala
    Victor, David
    Saharia, Ashish
    McMillan, Robert
    Al Najjar, Ebtesam
    Bugazia, Doaa
    Al-Rawi, Maryam
    Ghobrial, Rafik M.
    [J]. CURRENT ONCOLOGY, 2022, 29 (05) : 3585 - 3594
  • [9] PRE-OPERATIVE STAGING CONUNDRUM OF CHOLANGIOCARCINOMA AND ITS IMPACT ON CANDIDATE SELECTION AND OUTCOME FOLLOWING NEO-ADJUVANT PROTOCOL LIVER TRANSPLANTATION
    Panjala, Chakri
    Nguyen, Justin H.
    Nakhleh, Raouf E.
    Harnois, Denise M.
    [J]. HEPATOLOGY, 2009, 50 (04) : 1106A - 1107A
  • [10] FEASIBILITY OF EARLY EXTUBATION AND FAST-TRACKING AFTER LIVER TRANSPLANTATION-THE MAYO CLINIC FLORIDA EXPERIENCE
    Taner, Burcin
    Willingham, Darrin L.
    Bulatao, Ilynn G.
    Shine, Timothy S.
    Canabal, Juan
    Nguyen, Justin H.
    Kramer, David J.
    [J]. HEPATOLOGY, 2011, 54 : 628A - 628A
123